199 related articles for article (PubMed ID: 16190777)
21. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.
Zekri O; Hillard EA; Top S; Vessières A; Pigeon P; Plamont MA; Huché M; Boutamine S; McGlinchey MJ; Müller-Bunz H; Jaouen G
Dalton Trans; 2009 Jun; (22):4318-26. PubMed ID: 19662309
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, structural evaluation, and estrogen receptor interaction of 4,5-bis(4-hydroxyphenyl)imidazoles.
Gust R; Keilitz R; Schmidt K; von Rauch M
Arch Pharm (Weinheim); 2002 Dec; 335(10):463-71. PubMed ID: 12506394
[TBL] [Abstract][Full Text] [Related]
23. Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.
Lloyd DG; Hughes RB; Zisterer DM; Williams DC; Fattorusso C; Catalanotti B; Campiani G; Meegan MJ
J Med Chem; 2004 Nov; 47(23):5612-5. PubMed ID: 15509159
[TBL] [Abstract][Full Text] [Related]
24. N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies.
Raffa D; Maggio B; Cascioferro S; Raimondi MV; Daidone G; Plescia S; Schillaci D; Cusimano MG; Titone L; Colomba C; Tolomeo M
Arch Pharm (Weinheim); 2009 May; 342(5):265-73. PubMed ID: 19415659
[TBL] [Abstract][Full Text] [Related]
25. Conjugated indole-imidazole derivatives displaying cytotoxicity against multidrug resistant cancer cell lines.
James DA; Koya K; Li H; Chen S; Xia Z; Ying W; Wu Y; Sun L
Bioorg Med Chem Lett; 2006 Oct; 16(19):5164-8. PubMed ID: 16870446
[TBL] [Abstract][Full Text] [Related]
26. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, cyclooxygenase inhibitory effects, and molecular modeling study of 4-aryl-5-(4-(methylsulfonyl)phenyl)-2-alkylthio and -2-alkylsulfonyl-1H-imidazole derivatives.
Assadieskandar A; Amirhamzeh A; Salehi M; Ozadali K; Ostad SN; Shafiee A; Amini M
Bioorg Med Chem; 2013 Apr; 21(8):2355-2362. PubMed ID: 23473947
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological studies of silver N-heterocyclic carbene complexes derived from 4,5-diarylimidazole.
Liu W; Bensdorf K; Hagenbach A; Abram U; Niu B; Mariappan A; Gust R
Eur J Med Chem; 2011 Dec; 46(12):5927-34. PubMed ID: 22019187
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors.
Lee J; Choi H; Kim KH; Jeong S; Park JW; Baek CS; Lee SH
Bioorg Med Chem Lett; 2008 Apr; 18(7):2292-5. PubMed ID: 18353638
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles.
Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Gdaniec M
Arch Pharm (Weinheim); 2007 Jul; 340(7):333-8. PubMed ID: 17611942
[TBL] [Abstract][Full Text] [Related]
31. Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines.
Lee J; Kim H; Yu H; Chung JY; Oh CH; Yoo KH; Sim T; Hah JM
Bioorg Med Chem Lett; 2010 Mar; 20(5):1573-7. PubMed ID: 20149658
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
El-Hawash SA; Wahab AE
Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity.
Subtel'na I; Atamanyuk D; Szymańska E; Kieć-Kononowicz K; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
Bioorg Med Chem; 2010 Jul; 18(14):5090-102. PubMed ID: 20594860
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
36. [N-ethyl- and [N,N'-diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II): structure and cytotoxic/estrogenic activity in breast cancer cells.
Gust R; Niebler K; Schönenberger H
J Med Chem; 2005 Nov; 48(23):7132-44. PubMed ID: 16279771
[TBL] [Abstract][Full Text] [Related]
37. Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.
Ott I; Schmidt K; Kircher B; Schumacher P; Wiglenda T; Gust R
J Med Chem; 2005 Jan; 48(2):622-9. PubMed ID: 15658875
[TBL] [Abstract][Full Text] [Related]
38. Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
von Rauch M; Busch S; Gust R
J Med Chem; 2005 Jan; 48(2):466-74. PubMed ID: 15658860
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
[TBL] [Abstract][Full Text] [Related]
40. [Cyclopentadienyl]metalcarbonyl complexes of acetylsalicylic acid as neo-anticancer agents.
Rubner G; Bensdorf K; Wellner A; Bergemann S; Ott I; Gust R
Eur J Med Chem; 2010 Nov; 45(11):5157-63. PubMed ID: 20828891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]